Buy Dr. Reddy's Laboratories, target Rs 3,000: Manas Jaiswal
Buy Dr. Reddy's Laboratories Ltd. at a price target of Rs 3000.0 and a stoploss at Rs 2885 from entry point.

Dr. Reddy's Laboratories Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 9246.80 Crore to Sales Value (98.79 % of Total Sales), Licence Fees which contributed Rs 55.80 Crore to Sales Value (0.59 % of Total Sales), Spent Chemicals which contributed Rs 29.70 Crore to Sales Value (0.31 % of Total Sales), Scrap which contributed Rs 16.00 Crore to Sales Value (0.17 % of Total Sales) and Other Operating Revenue which contributed Rs 11.00 Crore to Sales Value (0.11 % of Total Sales)for the year ending 31-Mar-2018.
For the quarter ended 31-12-2018, the company has reported a Consolidated sales of Rs 3786.10 Crore, up 2.70 % from last quarter Sales of Rs 3686.60 Crore and down -.52 % from last year same quarter Sales of Rs 3806.00 Crore Company has reported net profit after tax of Rs 491.40 Crore in latest quarter. The company’s top management includes Dr.Bruce L A Carter, Dr.Omkar Goswami, Mr.Allan Oberman, Mr.Anupam Puri, Mr.Bharat N Doshi, Mr.G V Prasad, Mr.K Satish Reddy, Mr.Leo Puri, Mr.Prasad R Menon, Mr.Sridar Iyengar, Ms.Kalpana Morparia, Ms.Shikha Sanjaya Sharma. Company has S R Batliboi & Associates LLP as its auditoRs As on 31-03-2019, the company has a total of 166,065,948 shares outstanding.
Download ET Markets APP